Literature DB >> 7867662

The metabolism of drugs by the gut flora.

M Mikov1.   

Abstract

Gut flora and gut contents can be considered as a system with huge metabolic capacity, qualitatively and quantitatively different from the body cells and organs. That system changes along with life and nutrition, but despite broad investigation has not yet been defined satisfactorily. In many cases inter individual and intra individual differences in drug metabolism could be linked to variations in the gut flora metabolism. Gut flora metabolism of drugs and other xenobiotic metabolites excreted in bile is the key phase responsible for enterohepatic circulation. In the last decade there has been more and more evidence for the crucial role of the gut flora cysteine conjugate beta-lyase in the metabolism of cysteine conjugates. A new pathway for paracetamol cysteine conjugate metabolism has been directly linked with gut flora activity, as demonstrated in our studies. Nowadays, it is quite clear that gut flora metabolism must be considered an integral part of drug metabolism and toxicity studies.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7867662     DOI: 10.1007/BF03188922

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  55 in total

1.  Effects of high risk and low risk diets for colon carcinogenesis on fecal microflora and steroids in man.

Authors:  B S Reddy; J H Weisburger; E L Wynder
Journal:  J Nutr       Date:  1975-07       Impact factor: 4.798

Review 2.  Metabolism of drugs and other xenobiotics in the gut lumen and wall.

Authors:  K F Ilett; L B Tee; P T Reeves; R F Minchin
Journal:  Pharmacol Ther       Date:  1990       Impact factor: 12.310

Review 3.  Metabolism of foreign compounds by gastrointestinal microorganisms.

Authors:  R R Scheline
Journal:  Pharmacol Rev       Date:  1973-12       Impact factor: 25.468

4.  Geographic differences in digoxin inactivation, a metabolic activity of the human anaerobic gut flora.

Authors:  V I Mathan; J Wiederman; J F Dobkin; J Lindenbaum
Journal:  Gut       Date:  1989-07       Impact factor: 23.059

5.  Effect of poly rI:rC treatment upon the metabolism of [14C]-paracetamol in the BALB/cJ mouse.

Authors:  C T Dolphin; J Caldwell; R L Smith
Journal:  Biochem Pharmacol       Date:  1987-11-15       Impact factor: 5.858

Review 6.  Role of intestinal flora in metabolism of agrochemicals conjugated with glutathione.

Authors:  J E Bakke; J A Gustafsson
Journal:  Xenobiotica       Date:  1986 Oct-Nov       Impact factor: 1.908

7.  Human fecal flora: the normal flora of 20 Japanese-Hawaiians.

Authors:  W E Moore; L V Holdeman
Journal:  Appl Microbiol       Date:  1974-05

8.  The role of glutathione conjugate metabolism and cysteine conjugate beta-lyase in the mechanism of S-cysteine conjugate toxicity in LLC-PK1 cells.

Authors:  J Stevens; P Hayden; G Taylor
Journal:  J Biol Chem       Date:  1986-03-05       Impact factor: 5.157

9.  Biological activities of the intestinal microflora in mice treated with antibiotics or untreated and the effects of the microflora on absorption and metabolic activation of orally administered glutathione conjugates of K-region epoxides of 1-nitropyrene.

Authors:  T Kinouchi; K Kataoka; K Miyanishi; S Akimoto; Y Ohnishi
Journal:  Carcinogenesis       Date:  1993-05       Impact factor: 4.944

10.  In vitro metabolism of the methylthio group of 2-methylthiobenzothiazole by rat liver.

Authors:  G L Larsen; J E Bakke; V J Feil; J K Huwe
Journal:  Xenobiotica       Date:  1988-03       Impact factor: 1.908

View more
  19 in total

Review 1.  Enterohepatic circulation: physiological, pharmacokinetic and clinical implications.

Authors:  Michael S Roberts; Beatrice M Magnusson; Frank J Burczynski; Michael Weiss
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 2.  Drug-gut microbiota interactions: implications for neuropharmacology.

Authors:  Jacinta Walsh; Brendan T Griffin; Gerard Clarke; Niall P Hyland
Journal:  Br J Pharmacol       Date:  2018-06-28       Impact factor: 8.739

Review 3.  Gut and root microbiota commonalities.

Authors:  Shamayim T Ramírez-Puebla; Luis E Servín-Garcidueñas; Berenice Jiménez-Marín; Luis M Bolaños; Mónica Rosenblueth; Julio Martínez; Marco Antonio Rogel; Ernesto Ormeño-Orrillo; Esperanza Martínez-Romero
Journal:  Appl Environ Microbiol       Date:  2012-10-26       Impact factor: 4.792

4.  Colonization by non-pathogenic bacteria alters mRNA expression of cytochromes P450 in originally germ-free mice.

Authors:  L Jourová; P Anzenbacher; B Lišková; Z Matušková; P Hermanová; T Hudcovic; H Kozáková; L Hrnčířová; E Anzenbacherová
Journal:  Folia Microbiol (Praha)       Date:  2017-03-23       Impact factor: 2.099

5.  Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism.

Authors:  T Andrew Clayton; David Baker; John C Lindon; Jeremy R Everett; Jeremy K Nicholson
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-10       Impact factor: 11.205

6.  RNA-Seq Profiling of Intestinal Expression of Xenobiotic Processing Genes in Germ-Free Mice.

Authors:  Zidong Donna Fu; Felcy P Selwyn; Julia Yue Cui; Curtis D Klaassen
Journal:  Drug Metab Dispos       Date:  2017-09-22       Impact factor: 3.922

Review 7.  Understanding and modulating mammalian-microbial communication for improved human health.

Authors:  Sridhar Mani; Urs A Boelsterli; Matthew R Redinbo
Journal:  Annu Rev Pharmacol Toxicol       Date:  2013-10-23       Impact factor: 13.820

8.  Probiotic treatment reduces blood glucose levels and increases systemic absorption of gliclazide in diabetic rats.

Authors:  Hani Al-Salami; Grant Butt; J Paul Fawcett; Ian G Tucker; Svetlana Golocorbin-Kon; Momir Mikov
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2008 Apr-Jun       Impact factor: 2.441

9.  Arsenic metabolism by human gut microbiota upon in vitro digestion of contaminated soils.

Authors:  Tom Van de Wiele; Christina M Gallawa; Kevin M Kubachka; John T Creed; Nicholas Basta; Elizabeth A Dayton; Shane Whitacre; Gijs Du Laing; Karen Bradham
Journal:  Environ Health Perspect       Date:  2010-03-26       Impact factor: 9.031

10.  Comparative analysis of the gut microbiota in people with different levels of ginsenoside Rb1 degradation to compound K.

Authors:  Kyung-Ah Kim; Il-Hoon Jung; Se-Hoon Park; Young-Tae Ahn; Chul-Sung Huh; Dong-Hyun Kim
Journal:  PLoS One       Date:  2013-04-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.